Findings reveal that 97% of Americans are currently trying to make changes to better their own lives or plan to in the immediate future — but nearly one in five don’t know where to begin

NEW YORK, December 16, 2021--(BUSINESS WIRE)--Noom, a leading digital health platform focused on behavior change, today released the findings from its first-ever ‘State of Healthy Behaviors’ report, the result of a three-country consumer survey conducted to uncover how people think about improving their health – and what they do about it. The report, which features findings from the survey alongside insights from Noom’s behavior change experts, reveals a disconnect between individuals’ long-term health goals and their daily behaviors.

Even at a time when health is top of mind for so many with the ongoing pandemic, people across various geographies, generations, and backgrounds are facing challenges when it comes to making their personal health a priority. While many tried to improve their health over the past year, including attempts to get more sleep, eat healthier, and lose weight, millions fell short. In fact, it’s been over a decade since Americans, Australians, and Brits have felt their healthiest, due to a number of factors including lack of confidence, resources, support, and motivation. And less than a quarter of survey respondents believe that it will be easy to change their habits. Underpinning all of the findings in the 2021 ‘State of Healthy Behaviors’ report is the fact that people know what they need to do to be healthier overall, but struggle with how to actually implement those changes in their daily lives.

"While the findings of the first ‘State of Healthy Behaviors’ report show a collective struggle in the effort to improve our health, they also show a major opportunity," said Andreas Michaelides, Ph.D., chief of psychology at Noom. "Seeking a healthier lifestyle is a first and major step toward a healthier future for people everywhere and through our years of research and building our platform, we know that achieving positive health outcomes is the result of hard work. These findings enable us to further fulfill our mission of helping people everywhere lead healthier lives by providing the tools and resources they need to get there."

Highlights From Noom’s 2021 ‘State of Healthy Behaviors’ Report

It’s been over a decade since Americans, Australians, and Brits have felt their healthiest.

82% percent of Americans, 86% of Australians, and 88% of Brits do not feel they are currently at their peak physical and mental fitness.

It’s been 11 years since Americans have felt this way, 12 years for Australians, and 13 years for Brits.

While many attempted to improve their wellness over the past year, including getting more sleep, eating healthier, trying to lose weight, and being more physically active, millions fell short.

Collectively, over 170 million people formed bad habits during the pandemic (46% of the total U.S. population, 32% of the total AU population, and 18% of the total U.K. population).

Nearly one in five Americans, Australians, and Brits don't know where to begin to make changes in their life to be healthier.

Only 22% of Americans, 25% of Australians, and 22% of Brits agree that it’s easy to change their habits.

Affordability, accountability, and time come in as the top barriers preventing them from doing so.

People think of their doctors as resources, but many are not getting the support they need from them.

In fact, only 29% of Americans, 25% of Australians, and 13% of Brits, think of their doctor as a true partner on their health journeys, and just 14% of Americans, 13% of Australians, and 8% of Brits feel their doctors hold them accountable to achieving their health goals.

Nearly all (97%) of Americans report they are currently trying to make changes to better their own lives or plan to in the immediate future.

Of them, over half (52%) are seeking these changes as a gift to themselves to be the healthiest versions of themselves as possible.

To download the full 2021 ‘State of Healthy Behaviors’ report, visit www.noom.com/state-of-healthy-behaviors-2021

Noom commissioned an online survey managed by Kelton Global, a Material Company, which was fielded in Noom's top markets (U.S., U.K., AU) in November 2021.

n=1,011 in the U.S.; n=1,009 in AU; n=2,024 in U.K.; general population, ages 18+.

Noom is a consumer-first digital health platform that empowers its users to achieve holistic health outcomes through behavior change. Founded in 2008, Noom’s mission is to help people everywhere lead healthier lives. Fueled by a powerful combination of technology, psychology, and human coaching, Noom is backed by more than a decade of user research and product development. Today, Noom’s platform includes two core programs: Noom Weight for weight management and Noom Mood for stress management. Headquartered in New York City, Noom has been named one of Inc.'s Best Places to Work and Fortune’s Best Workplaces in Technology. Learn more by visiting noom.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211215006129/en/

Noom Emma Frane VP, Communications comms@noom.com

The past 20 months have been good for growth stocks, to say the least. In that time, the S&P 500 just about doubled, while the NASDAQ has done even better, gaining 125%. Corporate earnings strongly rebounded this year, post-COVID, and the government’s stimulus payments have helped put consumers and investors flush with cash. Most of the factors that have support the markets are still in play. Corporate earnings and consumer cash holdings remain high, interest rates are at rock bottom, and stocks

The Food and Drug Administration’s authorization of Pfizer (ticker: PFE) Covid-19 pill Paxlovid on Wednesday offered some hope. The authorization represents an extraordinary coup for Pfizer, its second of the pandemic. Analysts expect Pfizer to sell $21.7 billion worth of the drug in 2022, according to FactSet, though the company now says that it will make 120 million courses of the drug next year, 40 million more than previously forecast, which will probably drive those estimates higher.

Pfizer, AstraZeneca, and Novavax will be important players in the next stages of the world's battle against the pandemic.

New variant thought to develop in sufferers at faster pace than original Covid strain

The Omicron variant of COVID-19 has surged worldwide in record time—it was only three weeks ago that the first case was identified in South Africa. Last week, it accounted for 73% of new COVID infections in the United States, according to the latest CDC data. It's highly contagious—scientists estimate it's twice as transmissible as the Delta variant, which itself was twice as transmissible as the original COIVD strain—which calls for an abundance of caution. How do you know if you've been infect

Dr. David Katz, preventive medicine specialist and president at the True Health Initiative, reacts to the recent approval of COVID-19 pills from Pfizer and Merck, and how much of a difference the pills will make in combating COVID-19's spread.

A mysterious illness has reportedly killed nearly 100 people in South Sudan, prompting the World Health Organization (WHO) to launch […] The post Mysterious illness in South Sudan being investigated by World Health Organization appeared first on TheGrio.

Dr. Angelique Coetzee, the South African doctor who is credited with helping to spot the omicron variant, offers a few intriguing findings about the strain.

Novavax CEO Stanley Erck speaks with Yahoo Finance Live about the efficacy of Novavax vaccines and the path to FDA authorization amid a surge of the Omicron variant.

About 10.4% of coronavirus tests in the state were reported positive as of Dec. 20.

California's winter COVID-19 surge intensified Wednesday, with new overall coronavirus cases likely tied to holiday gatherings spiking up, along with confirmed cases of the Omicron strain.

The effects of the trial that began 10 years ago this past summer can still be seen today in the approach biotech companies take to developing drugs for rare diseases.

Our species lived through the Spanish flu, polio, ebola, SARS, and swine flu. How have humans gotten themselves out of pandemics in the past? And how might we get out of this one?

Up to one in three Covid patients may have caught the illness in hospital, official figures show - amid warnings over any use of data to justify new lockdown restrictions.

State health officials said they are preparing to receive two newly approved antiviral medications to treat COVID-19 "within the coming weeks."

Procter and Gamble is recalling over 30 dry shampoo and conditioner products from brands like Pantene and Herbal Essences due to Benzene concerns.

Barbara "Corki" Rawlings, age 86, celebrates one year since she first picked up the weights and began strength training in a video from Starting Strength.

Researchers may have discovered an effective prevention treatment strategy for inhibiting the virus that causes COVID-19 and its mutations, according to the results of a recent study.

Pfizer's pending acquisition of Arena Pharma includes Olorinab, a candidate that acts with the cannabinoid type 2 receptor to treat gastrointestinal disorders.

Los Angeles County reported nearly 10,000 new coronavirus cases Friday as the highly infectious Omicron variant spread across California.